CME Group
CME
Market cap $99B

274.70 USD

-3.12

1.12%

At close Jul 18, 4:00 PM EDT

After hours

274.70

+0.00

0.00%

1 day

-1.12%

5 days

-0.63%

1 month

0.96%

3 months

5.52%

6 months

18.28%

Year to date

18.04%

1 year

36.93%

5 years

63.61%

10 years

175.14%

About: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Employees: 3,760

Financials Financial Data & Stock Exchanges

0

Funds holding %

of 7,321 funds

0

Analysts bullish %

of 8 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

125% more first-time investments, than exits

New positions opened: 207 | Existing positions closed: 92

36% more call options, than puts

Call options by funds: $579M | Put options by funds: $427M

17% more funds holding in top 10

Funds holding in top 10: 53 [Q4 2024] → 62 (+9) [Q1 2025]

16% more capital invested

Capital invested by funds: $74.4B [Q4 2024] → $86.6B (+$12.2B) [Q1 2025]

6% more funds holding

Funds holding: 1,473 [Q4 2024] → 1,562 (+89) [Q1 2025]

6% more repeat investments, than reductions

Existing positions increased: 586 | Existing positions reduced: 552

0.19% more ownership

Funds ownership: 88.09% [Q4 2024] → 88.28% (+0.19%) [Q1 2025]

See Fund Rankings

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$211

23%

downside

Avg. target

$283

3%

upside

High target

$305

11%

upside

8 analyst ratings

4 positive

50%

3 neutral

38%

1 negative

13%

Piper Sandler Patrick Moley	8%upside $296	Overweight Maintained	15 Jul 2025
Barclays Benjamin Budish	9%upside $299	Equal-Weight Maintained	10 Jul 2025
Citigroup Christopher Allen	0%upside $275	Neutral Maintained	3 Jul 2025
Oppenheimer Owen Lau	9%upside $300	Outperform Maintained	4 Jun 2025
UBS Alex Kramm	11%upside $305	Buy Maintained	25 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 16 articles about CME published over the past 30 days

Zacks Investment Research

Stay Ahead of the Game With CME (CME) Q2 Earnings: Wall Street's Insights on Key Metrics

Beyond analysts' top-and-bottom-line estimates for CME (CME), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

Stay Ahead of the Game With CME (CME) Q2 Earnings: Wall Street's Insights on Key Metrics

Zacks Investment Research

Why Investors Need to Take Advantage of These 2 Finance Stocks Now

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Why Investors Need to Take Advantage of These 2 Finance Stocks Now

Zacks Investment Research

CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth

CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth

Zacks Investment Research

Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year

Record Europe, Middle East and Africa (EMEA) ADV of 6.7M, up 15% in Q2 2025 Record Asia Pacific (APAC) ADV of 2.2M, up 30% in Q2 2025 LONDON and SINGAPORE , July 10, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 9.2 million contracts in Q2 2025, up 18% year over year. Reflecting all trading reported outside the United States, this growth was driven by record quarterly ADV in EMEA and APAC.

CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year

Zacks Investment Research

3 Crypto-Focused Stocks to Buy as Bitcoin Heads Toward New High

With Bitcoin holding near $109K and optimism rising, V, CME, and BLK emerge as top crypto-exposed stocks to watch now.

3 Crypto-Focused Stocks to Buy as Bitcoin Heads Toward New High

CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win

CME Group gets rated buy again, reaffirming my last rating. The firm is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key peers, and cashflow growth. Two key business segments of operating exchanges, as well as providing market data to subscribers, have seen demand growth.

CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win

If I Could Only Buy 2 Dividend Stocks Right Now - These Would Be It

Inflation isn't going away. In fact, it may soon be fueled deliberately. That makes owning hard assets and top-tier dividend stocks essential. I've identified two stocks that thrive in this new reality, each built to handle inflation, deliver income, and offer long-term upside. These aren't random picks. They're special. If I could buy only two dividend stocks for what's coming, I'd seriously consider these.

If I Could Only Buy 2 Dividend Stocks Right Now - These Would Be It

Zacks Investment Research

Could CME Group's FX Tape+ be the Key to a More Transparent FX Market?

CME is launching FX Tape+ to unify fragmented FX data into a real-time, centralized reference for global market transparency.

Could CME Group's FX Tape+ be the Key to a More Transparent FX Market?

CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures

CHICAGO , July 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it has completed its first physical delivery cycle of Hard Red Spring Wheat futures, with 182 contracts delivered on July 1, 2025, the first delivery date since the product's April 14 launch. "Completion of the first delivery cycle is another important milestone for our new Hard Red Spring Wheat futures contract," said John Ricci, Managing Director and Global Head of Agricultural Products at CME Group.

CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures

See News Rankings

Charts implemented using Lightweight Charts™